Didac Mauricio, MD, PhD, is the Director of the Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, and a Professor with the Faculty of Medicine, University of Vic & Central University of Catalonia (UVic/UCC). He is also the Scientific Director of CIBER of Diabetes and Associated Metabolic Disease at the Instituto de Salud Carlos III in Spain. He is leading the Diabetes Research Group at his current institution. He has received the highest awards from the Spanish Society of Diabetes and the Spanish Society of Endocrinology & Nutrition. He has also served as a member of several local and international committees. He has been the principal investigator of multiple research projects funded by national and international agencies. He keeps a strong interest in current clinical issues in diabetes management, including randomized clinical trials and clinical research on diabetic complications, as well as in studies on real-world evidence.
Research Keywords & Expertise
Diabetic Retinopathy
diabetes mellitus
diabetes Complications
Cardiovascular Disease...
Nutrition And Diabetes
Real-World Evidence
Fingerprints
35%
diabetes mellitus
10%
Diabetic Retinopathy
5%
diabetes Complications
5%
Nutrition And Diabetes
5%
Real-World Evidence
Short Biography
Didac Mauricio, MD, PhD, is the Director of the Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau, and a Professor with the Faculty of Medicine, University of Vic & Central University of Catalonia (UVic/UCC). He is also the Scientific Director of CIBER of Diabetes and Associated Metabolic Disease at the Instituto de Salud Carlos III in Spain. He is leading the Diabetes Research Group at his current institution. He has received the highest awards from the Spanish Society of Diabetes and the Spanish Society of Endocrinology & Nutrition. He has also served as a member of several local and international committees. He has been the principal investigator of multiple research projects funded by national and international agencies. He keeps a strong interest in current clinical issues in diabetes management, including randomized clinical trials and clinical research on diabetic complications, as well as in studies on real-world evidence.